Skip to content

Choriogonadotropin Alfa

Published: July 26, 2026Updated: July 26, 2026

Ovidrel is a brand-name fertility medication containing choriogonadotropin alfa, a recombinant form of human chorionic gonadotropin (hCG). It is used to trigger ovulation in women undergoing fertility treatments and is an important component of assisted reproductive technologies. The medication is administered as a subcutaneous injection and works by mimicking the natural hormone that stimulates the final maturation and release of eggs from the ovaries.

Quick summary

Ovidrel is a fertility hormone injection used to trigger ovulation in women undergoing fertility treatments.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
284818
Generic
Ovidrel
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Ovidrel is primarily used in women to trigger ovulation during fertility treatments, particularly in conjunction with assisted reproductive technologies (ART) such as in vitro fertilization (IVF) or intrauterine insemination (IUI). It may also be used in controlled ovarian hyperstimulation protocols.

Ovidrel contains choriogonadotropin alfa, a recombinant form of hCG that mimics the naturally occurring hormone. It binds to LH receptors in the ovaries, stimulating the final maturation of follicles and triggering the release of a mature egg (ovulation) approximately 36 hours after administration.

Ovidrel is a prescription-only medication administered as a subcutaneous injection. It should only be used under the supervision of a fertility specialist. Common side effects may include injection site reactions, abdominal discomfort, and ovarian hyperstimulation syndrome (OHSS) in some patients. Women with known allergies to hCG or who have certain medical conditions should not use this medication.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy